GPT Healthcare IPO fully subscribed: GMP, review to subscription status. Apply or not?

GPT Healthcare IPO fully subscribed: GMP, review to subscription status. Apply or not?

– GPT Healthcare IPO debuted on 22nd Feb 2024 in the Indian market. – Open for subscription until 26th Feb, offering a narrow window. – Issue price set at ₹177 to ₹186 per equity share.

Subscription status after two days: 0.85 times oversubscribed. – GPT Healthcare shares in grey market at ₹9 premium. – An improvement from zero on Thursday, signaling a shift.

Current GMP at ₹9, down ₹4 from the weekend. – Market observers attribute the rise to a trend reversal. – Dull response initially influenced the grey market sentiment.

By day 3, overall subscription at 1.18 times. – Retail portion oversubscribed 1.57 times. – NII segment booked 1.60 times; QIB portion at 0.19 times.

Leading brokerages, including Reliance Securities and Anand Rathi, suggest subscribing. – GPT Healthcare's strategic positioning in underserved healthcare markets noted. – Mahesh M Ojha from Hensex Securities advises long-term investment, emphasizing growth in the Indian healthcare delivery market.

Checkout, What Type of Companies Can Go Public in India?